Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Luft

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|June 20, 2020
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysisLorenz Selberg, Peter Stadtherr, Sascha Dietrich, et al.
Haematologica|April 16, 2016
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Myriam Labopin, Marie Robin, et al.
European Journal of Haematology|May 26, 2018
CD7 is expressed on a subset of normal CD34-positive myeloid precursorsKatharina Kriegsmann, Harald Löffler, Volker Eckstein, et al.
Blood Advances|July 21, 2023
EASIX-1year and late mortality after allogeneic stem cell transplantationLambros Kordelas, Tobias Terzer, Ted Gooley, et al.
European Journal of Anaesthesiology|November 11, 2025
Preoperative Endothelial Activation and Stress Index as a predictor of in-hospital mortality and postoperative complications in cardiac surgery with cardiopulmonary bypass: A retrospective cohort studyPatrick Rehn, Ioannis Tsoukakis, Peter Full, et al.
Journal of Immunological Methods|January 19, 2016
Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon betaChristina Hermanrud, Malin Ryner, Thomas Luft, et al.
Bone Marrow Transplantation|September 28, 2019
EASIX and mortality after allogeneic stem cell transplantationThomas Luft, Axel Benner, Tobias Terzer, et al.
Annals of the Rheumatic Diseases|April 1, 2024
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic diseaseKarolina Gente, Manuel Feisst, Dorothea Marx, et al.
Blood|May 10, 2003
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuliMichael Jefford, Max Schnurr, Tracey Toy, et al.
Leukemia Research|March 18, 2018
Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDSTobias Boch, Thomas Luft, Georgia Metzgeroth, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|June 20, 2020
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysisLorenz Selberg, Peter Stadtherr, Sascha Dietrich, et al.
Haematologica|April 16, 2016
Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemiaCharles Craddock, Myriam Labopin, Marie Robin, et al.
European Journal of Haematology|May 26, 2018
CD7 is expressed on a subset of normal CD34-positive myeloid precursorsKatharina Kriegsmann, Harald Löffler, Volker Eckstein, et al.
Blood Advances|July 21, 2023
EASIX-1year and late mortality after allogeneic stem cell transplantationLambros Kordelas, Tobias Terzer, Ted Gooley, et al.
European Journal of Anaesthesiology|November 11, 2025
Preoperative Endothelial Activation and Stress Index as a predictor of in-hospital mortality and postoperative complications in cardiac surgery with cardiopulmonary bypass: A retrospective cohort studyPatrick Rehn, Ioannis Tsoukakis, Peter Full, et al.
Journal of Immunological Methods|January 19, 2016
Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon betaChristina Hermanrud, Malin Ryner, Thomas Luft, et al.
Bone Marrow Transplantation|September 28, 2019
EASIX and mortality after allogeneic stem cell transplantationThomas Luft, Axel Benner, Tobias Terzer, et al.
Annals of the Rheumatic Diseases|April 1, 2024
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic diseaseKarolina Gente, Manuel Feisst, Dorothea Marx, et al.
Blood|May 10, 2003
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuliMichael Jefford, Max Schnurr, Tracey Toy, et al.
Leukemia Research|March 18, 2018
Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDSTobias Boch, Thomas Luft, Georgia Metzgeroth, et al.
Pageof 12